ELI-007

N/A

Report date: 2022/11/29 18:09:34

Base Information

Drug NameELI-007
Drug Alias NameELI-007
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionSerine/threonine-protein kinase B-raf modulators
TargetsSerine/threonine-protein kinase B-raf
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungColorectal Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesElicio Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesElicio Therapeutics
Inactive CompaniesN/A
Active IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungColorectal Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A